BioMarin CEO says 'the system will have to determine' the worth of its new $702,000 drug
April 28, 2017 at 18:58 PM EDT
Jim Cramer spoke with JJ Bienaimé for more on the company's newest drug that treats a very rare disease.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|